April 20, 2026 · 7 min read · Vitalix Team

Genetic Testing Alone Tells Half the Story. Here's What Completes It.

Over 40 million people have taken a consumer genetic test. Most of them looked at their ancestry, skimmed the health reports, and haven't opened the app since. The raw data file sits in a downloads folder, containing hundreds of thousands of genetic markers that no one is interpreting.

The problem isn't the data. It's that genetics alone is just one piece of the picture. Your DNA tells you what could happen. Your labs, wearables, and symptoms tell you what is happening. The real power is connecting them.

What your genetic test actually contains

A 23andMe or AncestryDNA raw data file has between 600,000 and 700,000 genetic markers. The consumer reports you see in the app cover a tiny fraction. Hidden in that file are clinically relevant variants across three categories that most people never see:

  • Pharmacogenomics (PGx) -- How your body metabolizes medications. There are 30 CPIC-recognized genes that determine whether drugs work for you, don't work, or cause dangerous side effects. Your genetic test raw data contains the markers to assess most of them.
  • Polygenic Risk Scores -- Your combined genetic predisposition for conditions like heart disease, type 2 diabetes, breast cancer, and Alzheimer's. These aren't single-gene tests -- they combine hundreds or thousands of variants to estimate your relative risk compared to the general population.
  • Pathogenic Variants -- Known disease-causing mutations in genes like BRCA1, BRCA2, MUTYH, and others. Consumer tests check some of these, but the raw data contains markers that the consumer reports don't surface.

The catch: a raw data file is meaningless without interpretation. And interpretation is meaningless without context.

Why genetics without context is just anxiety fuel

Telling someone they have an "elevated genetic risk for coronary artery disease" without knowing their current cholesterol levels, blood pressure, resting heart rate, and activity levels is irresponsible at best and anxiety-inducing at worst. The same genetic risk means very different things depending on what's actually happening in your body right now.

Consider two people with the same elevated polygenic risk score for type 2 diabetes:

  • Person A: Fasting glucose 102 mg/dL, A1c 5.9%, sedentary, BMI 31. The genetic risk is being expressed. This person needs action now.
  • Person B: Fasting glucose 85 mg/dL, A1c 5.1%, runs 30 miles a week, BMI 22. The genetic risk exists but isn't manifesting. This person needs monitoring, not panic.

Without the lab values, the wearable data, and the lifestyle context, both people get the same generic "elevated risk" report. That's the fundamental limitation of genetic testing in isolation.

How Vitalix connects the dots

Vitalix was built to solve exactly this problem. When you upload your genetic data (from 23andMe or AncestryDNA), here's what happens:

1. Your genome is analyzed across 30 pharmacogenomic genes

Not the 5 genes consumer tests show you. Vitalix checks all 30 CPIC-recognized genes with star allele definitions, diplotype-to-phenotype mapping, and 115 drug-gene pair recommendations. If you're on a medication that your body metabolizes differently due to your genetics, the AI flags it immediately.

And it doesn't just say "you're a poor metabolizer." It cross-references your actual medication list. If you're taking metoprolol and you're a CYP2D6 poor metabolizer, Vitalix tells you that the drug may accumulate to higher levels in your system and suggests discussing dosage adjustment with your doctor.

2. Polygenic risk scores meet your real-world data

Vitalix calculates risk scores for conditions like coronary artery disease, type 2 diabetes, and breast cancer. But then it does something no genetic testing company does: it shows you where you are right now on that risk trajectory.

If your genetic risk for heart disease is elevated, Vitalix pulls in your latest lipid panel, your resting heart rate trends from your Apple Watch or Oura Ring, your blood pressure readings, your HRV patterns, and your activity levels. The AI gives you a contextualized assessment: "Your genetic risk is above average, but your current cardiovascular markers are strong -- your HDL is protective, your resting HR is athlete-level, and your HRV trends are stable. Keep doing what you're doing."

That's infinitely more useful than a standalone risk score.

3. Pathogenic findings trigger proactive screening recommendations

If Vitalix detects a pathogenic variant in a gene like BRCA1, it doesn't just report it. It references NCCN and USPSTF screening guidelines to recommend what clinical follow-up makes sense for your age, sex, and family history. And it adds that context to every AI conversation you have, so your health coach, oncology support agent, or any of the 27 specialists is aware of your genetic profile when giving advice.

4. The AI agents are genetically aware

Every one of Vitalix's 27 specialist AI agents has access to your genomic context. When the Sleep Specialist analyzes why your sleep quality dropped, it considers whether you're a fast caffeine metabolizer (CYP1A2). When the Medication Advisor checks your new prescription, it knows your CYP2D6 and CYP2C19 status. When the Cardiologist reviews your heart data, it factors in your genetic cardiovascular risk.

This isn't a separate "genetics section" of the app. It's woven into every health insight, every recommendation, every experiment.

For oncology patients: tumor analysis meets germline genetics

If you've had a tumor panel done (FoundationOne, Tempus, Guardant), you can upload the PDF report to Vitalix. The app classifies somatic mutations using OncoKB actionability levels, matches you with FDA-approved and investigational therapies, and searches ClinicalTrials.gov for eligible trials.

But here's where germline meets somatic: Vitalix cross-references your tumor mutations with your inherited genetic data. If you have a BRCA1 germline mutation and your tumor shows a BRCA-associated somatic profile, the AI flags PARP inhibitor eligibility. If your pharmacogenomics show you're a DPYD poor metabolizer and your oncologist is considering fluoropyrimidine chemotherapy, Vitalix raises a critical safety flag before you start treatment.

These cross-references happen automatically. You don't need to be a geneticist to benefit from them.

Privacy: your DNA never leaves your device

We made a deliberate architectural decision: your raw genetic file is parsed entirely in your browser. The full genome file never uploads to our servers. Only the clinically relevant markers (a tiny subset) are stored, encrypted, and used for analysis. You can delete your genomic data at any time.

Before any health data reaches our AI, personally identifiable information is stripped. The AI sees "52-year-old female with elevated cardiac risk score and CYP2D6 poor metabolizer status" -- not your name, email, or Social Security number.

What you can do today

If you have an old 23andMe or AncestryDNA raw data file:

  • Download Vitalix from the App Store or Google Play
  • Go to Devices and upload your raw data file (.txt format)
  • In about 60 seconds, you'll have a full pharmacogenomic report, risk scores, and pathogenic variant screening
  • Connect a wearable (Apple Watch, Oura, Fitbit, WHOOP, Garmin) and upload any lab results to complete the picture
  • Ask the AI: "How do my genetics affect my medications?" or "What does my cardiac risk score mean given my current lab results?"

Your genetic data has been sitting unused for years. It's time it started working for you -- not in isolation, but connected to everything else you know about your health.

Vitalix is free during beta. Available on iOS, Android, and web.

Ready to prove what works for your body?

Vitalix runs structured N-of-1 experiments with your health data. Free to start.

Start Your First Experiment
← All posts